Compare LXFR & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXFR | TKNO |
|---|---|---|
| Founded | 1898 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.6M | 482.7M |
| IPO Year | 2002 | 2021 |
| Metric | LXFR | TKNO |
|---|---|---|
| Price | $17.24 | $7.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | ★ $16.70 | $9.67 |
| AVG Volume (30 Days) | 427.6K | ★ 656.8K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $384,600,000.00 | $40,520,000.00 |
| Revenue This Year | N/A | $13.54 |
| Revenue Next Year | $4.99 | $14.51 |
| P/E Ratio | $50.63 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $11.26 | $1.91 |
| 52 Week High | $19.45 | $9.48 |
| Indicator | LXFR | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 48.52 |
| Support Level | $17.19 | $4.89 |
| Resistance Level | $17.38 | $7.66 |
| Average True Range (ATR) | 0.04 | 0.64 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 42.11 | 74.60 |
Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.